HomeInsights52 Week Low Stocks

Kwality Pharmaceuticals Ltd 52 Week Low

Kwality Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 1.9 Cr

Volume Transacted

(Jan 6, 2025)

stocks purchased

21.2 K

Stocks Traded

(Jan 6, 2025)

Last Updated on: Jan 06, 2025

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

YEARLOW

₹ 393.15

Last updated on: Jan 06, 2025

Key Highlights

  • The 52 Week Low of Kwality Pharmaceuticals Ltd is ₹ 393.15 as of 06 Jan 25 .

Company Fundamentals for Kwality Pharmaceuticals Ltd

No data available

Market Price of Kwality Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Kwality Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Jan 2025902.4
03 Jan 2025923.05
02 Jan 2025904.7
01 Jan 2025867.3
31 Dec 2024866.8
30 Dec 2024870.5
27 Dec 2024888.9
26 Dec 2024877.85
24 Dec 2024896.65
23 Dec 2024879.8

Asset Value vs Market Value of Kwality Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Kwality Pharmaceuticals Ltd News Hub

News

Kwality Pharmaceuticals update on pre-clinical studies of Erythropoietin

Kwality Pharmaceuticals (KPL) has secured approval from the Review Committee on Genetic Ma...

Read more

02 Jan 2025 15:37

News

Kwality Pharma gains on securing RCGM approval for Erythropoietin

Erythropoietin is a critical therapeutic used to treat anemia associated with chronic kidn...

Read more

02 Jan 2025 14:28

News

Kwality Pharma gains on securing SAHPRA approval for Tamoxifen tablet

The approval was granted through a site transfer process for the company's prominent oncol...

Read more

24 Dec 2024 15:07

News

Kwality Pharma gains on receiving nod for PEGylated-Asparaginase

L-Asparaginase is an E. coli-derived enzyme primarily used in the treatment of acute lymph...

Read more

26 Nov 2024 11:55

News

Kwality Pharmaceuticals to hold board meeting

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30...

Read more

23 Oct 2024 10:21

News

Kwality Pharmaceuticals schedules AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wil...

Read more

10 Sep 2024 10:31

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Kwality Pharmaceuticals Ltd

Why is it important to track the 52-week low of Kwality Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Kwality Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Kwality Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Kwality Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Kwality Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Kwality Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Kwality Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Kwality Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Kwality Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Kwality Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Kwality Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Kwality Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Kwality Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions